In addition to confirming the clinical relevance of CD4+ T cell response to HIPs in human T1D, this work shows that C-peptide is a major source of HIPs recognized by human islet-infiltrating CD4+ T cells. The gene discussed is CD4; the disease is type 1 diabetes mellitus.